UNSPSC 51471503: Dibromopropamidine or dibrompropamidine

This classification denotes a topical anti-infective agent with the molecular formula C17H18Br2N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 269M3QL74S, chemically known as 4,4-(trimethylenedioxy)bis(3-bromobenzamidine) but generally known as dibromopropamidine, which bears US NIH Compound Identifier 11974. European Medicines Agency schedules Dibrompropamidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07075MIG.

UNSPSC 51471503 Dibromopropamidine or dibrompropamidine is a Commodity code covering a specific antimicrobial chemical agent used in disinfectants and surface-cleaning preparations for institutional and healthcare settings. State and local governments procure this ingredient as part of broader janitorial, operational, and pharmaceutical supply contracts supporting fire departments, public health facilities, and other government operations. The actual buying reflects demand for approved antimicrobial compounds embedded in larger consumables-management programs rather than purchases of the raw chemical in isolation.

Recent state and local activity under this code spans county procurement offices and multistate cooperative purchasing alliances. Hillsborough County Board of County Commissioners (Florida) issued an ITB on July 7, 2026, for consumable janitorial and operational supplies across 47 fire stations, with bids due July 24, 2026, under a one-year contract estimated at $765,679.84; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026, for generic multi-source pharmaceuticals and OTC products distributed to participating state and local facilities including Oregon, with proposals due March 26, 2026, and awarded vendors effective July 1, 2026. Geographic activity centers on the upper Midwest and Florida, with cooperative purchasing vehicles extending reach across multiple states. Bidders on these opportunities must meet FDA compliance, cGMP certification, and Drug Supply Chain Security Act requirements; Hillsborough County requires authorized distributor status, new products in original packaging, and standard delivery within ten days or emergency delivery within five business days to a single operations complex in Tampa.